Medical Science Liaison (MSL) – Cardiometabolic
Core
Field-based scientific expert building trusted peer-to-peer relationships with healthcare professionals and KOLs to advance disease understanding and support future launch readiness for cardiometabolic therapies.
Role type
Senior IC Medical Science Liaison (MSL)
Builds
Scientific partnerships, medical education initiatives, and strategic insights for the cardiometabolic portfolio
Domain
Healthcare / Cardiometabolic diseases (lipidology, endocrinology, hepatology, gastroenterology, cardiology)
Required skills
Scientific exchange, KOL engagement, medical education, disease area expertise, strategic planning, evidence generation
Preferred skills
None stated
Technologies
None stated
Responsibilities
Develop and maintain strong scientific relationships with national, regional, and emerging key opinion leaders (KOLs) across Australia; Deliver high-quality, non-promotional scientific exchange with healthcare professionals and researchers; Develop and maintain deep scientific expertise in severe hypertriglyceridaemia (sHTG), familial chylomicronaemia syndrome (FCS), hypertriglyceridaemia-associated acute pancreatitis, rare lipid disorders, and cardiometabolic disease; Gather and communicate insights from healthcare professionals regarding unmet medical needs, current treatment practices, diagnostic challenges, referral pathways, future research opportunities, and emerging scientific trends; Identify investigators, treatment centres, and research networks with an interest in cardiometabolic and rare lipid diseases; Conduct all activities in compliance with the Medicines Australia Code of Conduct, TGA requirements, pharmacovigilance obligations, and Sobi policies
Seniority
Senior, hands-on IC